224 Preoperative Cerebrovascular Consultation Mayo Clin Proc, February 2004, Vol 79 Table 1. Perioperative Ischemic Stroke Risk Rates for Specific Sur

Size: px
Start display at page:

Download "224 Preoperative Cerebrovascular Consultation Mayo Clin Proc, February 2004, Vol 79 Table 1. Perioperative Ischemic Stroke Risk Rates for Specific Sur"

Transcription

1 Mayo Clin Proc, February 2004, Vol 79 Preoperative Cerebrovascular Consultation 223 Concise Review for Clinicians The Preoperative Cerebrovascular Consultation: Common Cerebrovascular Questions Before General or Cardiac Surgery DAVID J. BLACKER, FRACP; KELLY D. FLEMMING, MD; MICHAEL J. LINK, MD; AND ROBERT D. BROWN, JR, MD, MPH All types of health care providers may be called on to evaluate the risk of ischemic stroke related to an upcoming surgical procedure, particularly in patients with established cerebrovascular disease. We outline possible mechanisms contributing to perioperative stroke, summarize available data on the stroke risk associated with selected surgeries, and highlight recognized risk factors. We then provide recommended answers to some of the questions commonly encountered at the preoperative cerebrovascular consultation: What is the appropriate time interval between a stroke and elective surgery? What is the perioperative stroke risk for patients with established carotid or vertebrobasilar large artery stenosis, and what are the cardiac implications of detecting a cerebrovascular large artery stenosis? Should patients with a large artery stenosis undergo prophylactic revascularization procedures before undergoing general surgery? What treatment is appropriate for patients with both coronary artery and carotid or vertebrobasilar large artery stenosis? What is the appropriate perioperative management of antiplatelet and anticoagulant medications with respect to stroke risk? Mayo Clin Proc. 2004;79: AF = atrial fibrillation; CABG = coronary artery bypass graft; CAS = carotid angioplasty and stenting; CEA = carotid endarterectomy; MI = myocardial infarction; TIA = transient ischemic attack As the population ages, increasing numbers of elderly patients are considered to be candidates for surgical procedures. Because of the association between age and cerebrovascular disease, physicians likely will be consulted more frequently than in the past to assess the risk of stroke related to surgical procedures in patients with cerebrovascular conditions and to advise appropriate treatment. The advent of readily available noninvasive neurovascular imaging and the evolving use of endovascular revascularization techniques increasingly raise the issue of whether prophylactic preoperative large artery neurovascular procedures are indicated. Risks vs benefits of any prophylactic intervention need to be carefully balanced on the basis of available data about perioperative stroke risk. We summarize the available literature and answer specific questions that commonly arise in the preoperative cerebrovascular consultation. Note that in some areas, the evidence-based data are not strong; therefore, recommendations should be viewed accordingly. From the Department of Neurology (D.J.B., K.D.F., R.D.B) and Department of Neurologic Surgery (M.J.L.), Mayo Clinic College of Medicine, Rochester, Minn. Dr Blacker is now with the Sir Charles Gairdner Hospital, Perth, Australia. A question-and-answer section appears at the end of this article. Address reprint requests and correspondence to Robert D. Brown, Jr, MD, MPH, Department of Neurology, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN ( brown.robert@mayo.edu). THEORETICAL REASONS FOR PERIOPERATIVE STROKE There are numerous reasons why the immediate perioperative period may pose an increased risk for cerebrovascular events. Potential stroke mechanisms include hypoperfusion (global or focal), thromboembolism (cardiac or artery-to-artery), and hematologic mechanisms. 1 Aortic or cardiac sources of perioperative emboli include aortic arch atherosclerosis, perioperative myocardial infarction (MI), and arrhythmias such as atrial fibrillation (AF). Paradoxical cerebral embolism via a patent foramen ovale could potentially cause a stroke in patients with pelvic or lower limb venous thrombosis; fat emboli entering into the venous system during orthopedic surgery is another potential stroke mechanism in the presence of a patent foramen ovale. Carotid and vertebrobasilar large artery stenoses are potential causes of perioperative stroke. Changes in flow and perfusion during surgery could result in focal hypoperfusion in the distribution of the stenosed artery. 2 Iatrogenic injury to neck arteries during surgical dissection or from misplaced vascular access lines are other potential mechanisms. Neck extension for endotracheal intubation reduces basilar artery flow in the presence of vertebral artery hypoplasia, and although not confirmed, may be a potential stroke mechanism. Transient compression or stretching of the neck arteries in drowsy postoperative patients may allow thrombus formation and subsequent distal embolization. Mayo Clin Proc. 2004;79: Mayo Foundation for Medical Education and Research

2 224 Preoperative Cerebrovascular Consultation Mayo Clin Proc, February 2004, Vol 79 Table 1. Perioperative Ischemic Stroke Risk Rates for Specific Surgeries and Clinical Conditions* Stroke risk Surgery (%) General surgery General surgery with 6 or without carotid bruit 0.5 General surgery after prior stroke General surgery with carotid stenosis and bruit or prior symptoms CABG retrospective studies CABG prospective studies CABG surgery after prior stroke or TIA CABG surgery + valve surgery CABG surgery + unilateral >50% carotid stenosis CABG surgery + bilateral >50% carotid stenosis CABG surgery + carotid occlusion Surgery with symptomatic vertebrobasilar stenosis *CABG = coronary artery bypass graft; TIA = transient ischemic attack. Hematologic mechanisms may contribute to both ischemic and hemorrhagic perioperative stroke. The postoperative state is associated with changes in blood-clotting mechanisms, 3 and the withholding of antiplatelet or anticoagulant medications during the perioperative period might contribute to the risk of perioperative vascular events. Finally, there is a body of literature 4 concerning the relationship between infectious and inflammatory conditions and vascular disease; whether this issue is applicable to the postoperative state is not known. STROKE RISK RELATED TO SELECTED SURGERIES The stroke risk rates associated with specific surgical procedures and clinical situations are presented in Table It is useful to consider cardiac and general surgeries separately because cardiac patients often have more generalized atherosclerotic disease and the surgical procedures in these patients have an inherent risk for stroke. General surgery has an extremely low stroke risk in unselected patients of about 0.2%. 5 RISK FACTORS FOR PERIOPERATIVE STROKE The risk factor linked most consistently to perioperative ischemic stroke is a history of stroke. One study of 173 patients with a history of stroke found a 2.9% risk of stroke when patients underwent subsequent general surgeries. 7 Other factors that increase the stroke risk related to general surgeries include postoperative cardiac arrhythmias, peripheral vascular disease, 5 and chronic obstructive airway disease. In patients who underwent coronary artery bypass graft (CABG) surgery, a history of stroke or transient ischemic attack (TIA) increased the perioperative stroke rate to 8.5%, 1 compared with an overall risk of 1% to 2%. Stroke after CABG surgery is associated with advanced age, probably related to increased carotid stenosis and aortic arch atherosclerosis in older patients. Other risk factors include prolonged cardiopulmonary bypass, recent MI, left main stem coronary artery disease, repeated cardiac surgery, ventricular thrombus, postinfarction angina, cardiac failure, diabetes, smoking, and impaired renal function. 1 QUESTIONS COMMONLY ENCOUNTERED AT THE PREOPERATIVE CEREBROVASCULAR CONSULTATION Timing of Surgery in Relation to Stroke How long should general surgery under anesthesia be delayed after a stroke? Every patient who has had a stroke should be examined before undergoing elective nonurgent surgery so that the stroke mechanism can be defined and the optimal secondary prevention strategies can be clarified. This should include appropriate vascular imaging (eg, carotid ultrasonography, magnetic resonance angiography and/or computed tomographic angiography), cardiac studies (eg, electrocardiography and/or echocardiography when indicated), and any indicated blood tests. 9 Before undergoing general or cardiac surgery, symptomatic patients with an extracranial carotid stenosis greater than 70% should receive appropriate treatments including carotid endarterectomy (CEA) 10 or carotid angioplasty and stenting (CAS) in selected patients. There are few data to guide the timing of surgery in relation to stroke. Although some information regarding timing of surgery can be found in studies of CEA, most pertains to the risk of reperfusion hemorrhage, which is probably not an issue in other forms of surgery. There is information in the cardiac surgery literature 11,12 that pertains to patients with acute stroke who require urgent cardiac surgery; however, the data on the risk according to timing are conflicting and are often in the setting of infective endocarditis. Because clinical data are scant, we also consider pathophysiological data in our recommendations. There are theoretical reasons for recommending a delay between ischemic stroke and surgery, so that the brain may recover sufficiently before encountering the hemodynamic stresses associated with surgery and anesthesia. Recovery of cerebral autoregulation after stroke is an important factor that should be considered. The duration of markedly impaired autoregulation after stroke is unclear but is probably from days to 1 to 2 weeks. Pathologically, a cerebral infarct undergoes a series of changes mediated by inflammatory cells that soften the tissue and could potentially make it vulnerable during anesthesia and surgery to either hemorrhagic transformation or worsening ischemia. Ideally, sufficient time should pass for both these processes to occur; a month should be sufficient for most patients

3 Mayo Clin Proc, February 2004, Vol 79 Preoperative Cerebrovascular Consultation 225 including those with a moderately large cerebral infarct (greater than one third the distribution of the middle cerebral artery). Promptly examine all stroke patients, and defer nonessential surgery until the evaluation is complete. Treat symptomatic carotid stenosis with CEA or CAS before the patient undergoes general or cardiac surgery. Allow at least 1 month to elapse between a moderately large ischemic stroke (greater than one third the distribution of the middle cerebral artery) and surgery. Large Artery Stenosis and Surgery What is the stroke risk for patients with established carotid or vertebrobasilar large artery stenosis who undergo a surgical procedure, and what are the cardiac implications of detecting a cerebrovascular large artery stenosis? Most data suggest that carotid bruits and asymptomatic carotid stenoses do not increase the perioperative stroke risk related to noncardiac surgeries. 6,13 The issue is complicated by a study of patients with carotid bruits or prior cerebral ischemic symptoms in whom carotid ultrasonography was performed within 12 months before general surgery; the study found a perioperative stroke rate of 3.6% in these patients. 8 No clear relationship was found between severity of stenosis and stroke risk, although the increased risk may have been explained by the history of stroke. Patients found to have a carotid bruit at preoperative evaluation should undergo a detailed neurovascular history and examination. If there are no symptoms or signs of focal cerebral ishemia, then no further evaluation is necessary before general surgery. Patients with carotid stenosis who undergo CABG surgery have a higher risk of stroke than do those without carotid stenosis (Table 1). Although carotid stenosis is positively correlated with stroke after CABG surgery, this may be because carotid stenosis is a marker for advanced systemic atherosclerosis, specifically aortic arch atherosclerosis, rather than being causative for ischemic strokes. 1 Less than half of the increased risk is likely to be due to the carotid lesion. 1 Few data exist relating to the perioperative stroke risk associated with intracranial large artery stenosis; however, this issue is becoming more common as more patients undergo magnetic resonance angiography or computed tomographic angiography of the intracranial arteries as part of the cerebrovascular work-up. Recent data have shown that patients with symptomatic basilar or intracranial vertebral artery stenosis who undergo various vascular and nonvascular surgeries have a perioperative stroke risk of 6.0%, with prolonged intraoperative hypotension being implicated as a potential precipitating factor. 2 There are no data regarding perioperative stroke risk in the setting of large artery stenosis in the anterior intracranial circulation. Patients with extracranial internal carotid artery stenosis may have concurrent advanced coronary artery disease, which may be a concern in the perioperative period. Approximately 50% of patients with large artery ischemic stroke and no cardiac history have abnormal cardiac stress test results. 14 Summary and Asymptomatic carotid bruits and stenoses do not increase the stroke risk for patients who undergo general surgery. Carotid bruits and/or stenoses in asymptomatic and symptomatic patients who undergo CABG surgery are associated with a 5% to 7% risk of stroke. Symptomatic vertebrobasilar stenosis is associated with a 6% risk of stroke in patients who undergo general surgery or CABG surgery. The perioperative stroke risk in patients with intracranial large artery stenosis in the anterior circulation is unknown but is likely to be similar to the risk in symptomatic patients with vertebrobasilar stenosis (6%); the risk is likely to be extremely low in asymptomatic patients. Patients with large artery ischemic stroke should undergo an appropriate preoperative cardiac examination. Prophylactic Large Artery Surgery or Endovascular Repair Should a patient with a large artery stenosis undergo prophylactic revascularization procedures before undergoing general surgery? To determine whether a patient s perioperative stroke risk will be reduced by a prophylactic neurovascular procedure requires that the risk of this procedure be balanced against that of the intended subsequent surgery. The revascularization procedure will not entirely remove the perioperative stroke risk, particularly related to cardiac procedures, because there are other potential mechanisms for ischemic stroke (eg, aortic arch atherosclerosis). Any prophylactic neurovascular procedure followed by another surgery exposes a patient to the risk of periprocedural stroke twice. Although the prophylactic procedure is intended to reduce the perioperative stroke risk of the subsequent surgery, it will not reduce the risk to zero. The stroke risks related to CEA and endovascular procedures in various clinical circumstances are summarized in Table A further issue is the use of antiplatelet agents such as clopidogrel after stenting procedures. These medications are typically prescribed for at least several weeks to main-

4 226 Preoperative Cerebrovascular Consultation Mayo Clin Proc, February 2004, Vol 79 Table 2. Stroke Risk Related to Carotid Intervention* Stroke risk Procedure (%) CEA Asymptomatic stenosis (ACAS) Symptomatic stenosis (NASCET) Asymptomatic patients (AHA guidelines) 16 <3.0 Endovascular procedure ICA extracranial stent alone Stent + protection device Intracranial angioplasty and stent 19 (range 20 ) <10 (4-40) *ACAS = Asymptomatic Carotid Atherosclerosis Study; AHA = American Heart Association; CEA = carotid endarterectomy; ICA = internal carotid artery; NASCET = North American Symptomatic Carotid Endarterectomy Trial. tain stent patency. At least 1 week, and preferably 2 weeks, of clopidogrel cessation is necessary to allow platelet function to recover 21 to lessen the risk of hemorrhagic complications during subsequent surgery. The issue of prophylactic repair usually pertains to patients with asymptomatic large artery stenosis or to those with a distant history of cerebral ischemia because CEA or CAS is the standard of care for patients with symptomatic carotid artery stenosis. Because the perioperative stroke risk is low in patients with asymptomatic carotid stenosis, prophylactic CEA and screening for carotid artery stenosis in asymptomatic patients cannot be recommended. Few data exist about the approach to patients with intracranial arterial stenosis. For patients with actively symptomatic intracranial stenoses, it would seem reasonable to delay surgery as long as possible, aggressively treat the neurovascular disease, and possibly allow time for collateral vessel formation. The stroke and death rates for intracranial angioplasty and stenting procedures currently are based on a small series and range between 4% to 40%, 20 although some researchers believe that complication rates are less than 10%. 19 The stroke risk related to intracranial stenting likely exceeds the perioperative stroke risk for general surgery in asymptomatic patients and for many symptomatic patients. Patients with symptomatic extracranial carotid stenosis should undergo CEA or stenting before elective general surgery. Patients with recent symptomatic intracranial large artery stenosis should have surgery delayed for at least 1 month. Intraoperative hypotension must be avoided. There are insufficient data to make a recommendation for prophylactic endovascular revascularization procedures; however, the stroke risk from these procedures likely exceeds the stroke risk in these patients during general surgery. Patients with asymptomatic extracranial large artery stenosis do not require CEA or CAS before general surgery; the risks associated with CEA or CAS are higher than the perioperative stroke risk. Patients with asymptomatic intracranial arterial stenosis do not require preoperative intervention because the perioperative risks are lower than those for angioplasty and stenting. Combined Cardiac and Carotid Artery Stenosis What treatment is appropriate for patients with both coronary artery and carotid or vertebrobasilar large artery stenosis? Many patients undergoing cardiac procedures also have cerebrovascular disease. Studies examining the stroke risk during CABG surgery related to varying degrees of carotid stenosis are difficult to interpret because of their retrospective nature, small number of cerebral events, lack of data on the topography of the strokes, and the fact that some data are from CABG surgery combined with CEA. Naylor et al 1 noted the prevalence of carotid bruits in patients who underwent CABG surgery to be 9.9%; the prevalence was 6.8% in patients who underwent CABG surgery with a history of stroke or TIA. Although there is a relationship between carotid artery stenosis and the risk of stroke during CABG surgery (for reasons noted previously), extracranial carotid artery stenosis probably accounts for less than half the strokes related to CABG surgery. 1 Naylor et al 1 summarized the literature and derived the stroke risk rates according to varying degrees of carotid stenosis (Table 1). The treatment of patients with both symptomatic and asymptomatic cerebral and coronary lesions has been a subject of extensive discussion. Some researchers have recommended a simple treatment protocol that can be summarized as operate first on the symptomatic vascular lesion, and then treat the asymptomatic lesion at a later time. When there are active symptoms in both territories, a combined procedure may be considered. 22 Treatment guidelines are less clear-cut in patients with asymptomatic carotid stenosis who are to undergo CABG surgery. Most of the literature provides combined data from CABG procedures and CEA, yielding a perioperative stroke rate of 3.8%, MI rate of 3.2%, and death rate of 4.6%. 23 A staged approach, in which the CEA is performed before CABG surgery, has been studied less; it may have a lower stroke rate at 1.8% but at the expense of more MIs at 9.1% and more deaths at 6.6%. 23 A reversed staged approach, in which CABG surgery is done first and later followed by CEA, has the least number of studied patients and seems to yield a comparable percentage of strokes at 3.2%, but fewer MIs at 1.6% and deaths at 2%. 23 One metaanalysis 24 compared rates from combined CEA and CABG

5 Mayo Clin Proc, February 2004, Vol 79 Preoperative Cerebrovascular Consultation 227 surgery and found the combined approach had higher rates of stroke or death than staged approaches. Researchers recommended combined surgeries only for patients with symptoms in both circulations, for high-risk asymptomatic patients with bilateral high-grade stenosis, or for a highgrade carotid stenosis with a contralateral occlusion. 24 Although some researchers have suggested that prophylactic CEA simultaneous with CABG surgery is an acceptable indication for CEA, 16 others have concluded that there is no evidence from the substantive literature to suggest that this practice (or the staged approach) reduces stroke or death rates in this patient group. 23 The role of prophylactic carotid stenting for patients with combined coronary and carotid large artery stenosis is evolving. Currently, in patients not undergoing cardiac surgery, stenting for asymptomatic carotid stenosis cannot be routinely advised because there are insufficient data to support benefit; this is in contrast to CEA, for which a statistically significant benefit has been shown. 15 Because many potential mechanisms of ischemic stroke are related to CABG surgery, treatment of the carotid stenosis does not entirely remove the stroke risk for an individual patient. In patients having both coronary and extracranial large artery stenosis with one symptomatic and one asymptomatic circulation, the symptomatic lesion should be treated first with a staged procedure. Patients with symptomatic, active lesions in both circulations may consider combined CEA and CABG surgery; when possible, CAS should be considered for the extracranial carotid stenosis. Patients with isolated, asymptomatic unilateral carotid stenosis should not have combined CABG surgery and CEA because stroke and death rates are increased. If the asymptomatic lesion is treated at all, these patients could have a staged procedure, acknowledging that the MI and death rates may be higher when CEA or CAS is done first, although the stroke rate may be lowered. Selected high-risk asymptomatic patients (ie, with bilateral stenosis or contralateral occlusion) may consider combined CEA and CABG surgery; when possible, CAS should be considered as the initial procedure. Perioperative Management of Antiplatelet and Anticoagulant Medications How should antiplatelet and anticoagulant medications be managed in the perioperative period with respect to stroke risk? Many clinicians can recall patients who have had vascular events temporally related to the discontinuation of antiplatelet or anticoagulant medications. Case reports and series do little to accurately quantify the risk of this situation because many other patients safely undergo temporary discontinuation without adverse events. Theoretical models 25 have been used to estimate the risk of stroke in patients with AF when anticoagulation is temporarily withheld; these estimates are based on the annual stroke risks observed in large studies of AF. The models assume that the stroke risk during the perioperative period is no greater than at any other period without the protection of anticoagulation; for reasons cited earlier, this may not necessarily be the case. A review of 31 studies of anticoagulant management in the perioperative period found a stroke risk of 0.4%. 26 In a study of patients with AF who required warfarin cessation for endoscopy, the risk of stroke was 1.06% within 30 days of the procedure. Factors that put patients at higher risk for stroke included older age; history of hypertension, hyperlipidemia, or stroke; and family history of vascular disease. 27 In general, early postprocedure anticoagulation with heparin or low-molecular-weight heparin is recommended in patients with a history of stroke or other major risk factors for perioperative stroke. Withholding antiplatelet medications in the perioperative period may have adverse consequences. Studies from the cardiac literature have reported that MI, ischemic stroke, and other thrombotic events occur more frequently in patients not given aspirin in the immediate postoperative period after CABG surgery. 28 Because of the bleeding risk associated with other antiplatelet agents such as clopidogrel, these agents are commonly withheld for about 1 week (and preferably 2 weeks) before the patient undergoes surgical procedures. The risk of thrombotic events with shortterm clopidogrel cessation is unknown. The risk of thrombotic events occurring when anticoagulation is withheld for procedures in patients with AF or cardiac heart valve prostheses is low, but is higher in selected patients with risk factors. Aggressive, early postprocedure anticoagulant management (ie, with heparin or low-molecular-weight heparin) is recommended in patients with a history of stroke or other major risk factors for perioperative stroke. If a patient has been taking aspirin, particularly for secondary prevention of vascular events, this should be continued throughout the perioperative period unless the procedure has a high risk of hemorrhagic complications. Other agents such as clopidogrel are usually stopped for at least 1 week and preferably 2 weeks because of the risk of perioperative hemorrhage. CONCLUSIONS Although stroke related to surgical procedures represents a small percentage of the total stroke burden, it occurs in a

6 228 Preoperative Cerebrovascular Consultation Mayo Clin Proc, February 2004, Vol 79 potentially predictable group of patients in whom careful assessment and management might feasibly reduce the likelihood of stroke. With the increasing availability of vascular procedures such as angioplasty and stenting, we anticipate that an increasing number of patients will be assessed for prophylactic vascular intervention before elective surgery. There is some danger that unnecessary procedures could be performed that have a higher stroke risk than that posed by the index surgery; this danger makes careful consideration of the perioperative stroke risk imperative. Careful comparison of the risks of a vascular intervention to the stroke risk reduction possibly promoted by the procedure are needed in patients with cerebrovascular disease requiring general, cardiac, or other surgery. REFERENCES 1. Naylor AR, Mehta Z, Rothwell PM, Bell PR. Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature. Eur J Vasc Endovasc Surg. 2002;23: Blacker DJ, Flemming KD, Wijdicks EF. Risk of ischemic stroke in patients with symptomatic vertebrobasilar stenosis undergoing surgical procedures. Stroke. 2003;34: Rem J, Feddersen C, Brandt MR, Kehlet H. Postoperative changes in coagulation and fibrinolysis independent of neurogenic stimuli and adrenal hormones. Br J Surg. 1981;68: Zebrack J, Anderson JL. The role of inflammation and infection in the pathogenesis and evolution of coronary artery disease. Curr Cardiol Rep. 2002;4: Larsen SF, Zaric D, Boysen G. Postoperative cerebrovascular accidents in general surgery. Acta Anaesthesiol Scand. 1988;32: Ropper AH, Wechsler LR, Wilson LS. Carotid bruit and the risk of stroke in elective surgery. N Engl J Med. 1982;307: Landercasper J, Merz BJ, Cogbill TH, et al. Perioperative stroke risk in 173 consecutive patients with a past history of stroke. Arch Surg. 1990;125: Evans BA, Wijdicks EF. High-grade carotid stenosis detected before general surgery: is endarterectomy indicated? Neurology. 2001;57: Brown RD Jr, Evans BA, Wiebers DO, Petty GW, Meissner I, Dale AJ, Mayo Clinic Division of Cerebrovascular Disease. Transient ischemic attack and minor ischemic stroke: an algorithm for evaluation and treatment. Mayo Clin Proc. 1994;69: Barnett HJ, Taylor DW, Eliasziw M, et al, North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 1998;339: Zisbrod Z, Rose DM, Jacobwitz IJ, Kramer M, Acinapura AJ, Cunningham JN Jr. Results of open heart surgery in patients with recent cardiogenic embolic stroke and central nervous system dysfunction. Circulation. 1987;76(5, pt 2):V109-V Maruyama M, Kuriyama Y, Sawada T, Yamaguchi T, Fujita T, Omae T. Brain damage after open heart surgery in patients with acute cardioembolic stroke. Stroke. 1989;20: Gerraty RP, Gates PC, Doyle JC. Carotid stenosis and perioperative stroke risk in symptomatic and asymptomatic patients undergoing vascular or coronary surgery. Stroke. 1993;24: Chimowitz MI, Poole RM, Starling MR, Schwaiger M, Gross MD. Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke. 1997;28: Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273: Biller J, Feinberg WM, Castaldo JE, et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 1998;97: Wholey M, Toursarkissian B, Ferral H. Current status in cervical carotid artery stent placement. Semin Cerebrovasc Med Stroke. 2002;2: Wholey MH. The ARCHeR Trial: results for carotid stenting in high surgical risk patients: preliminary 30 day results. Presented at: 52nd Annual Scientific Session of the American College of Cardiology; Chicago, Ill; March 30, Gomez CR, Orr SC. Angioplasty and stenting for primary treatment of intracranial arterial stenoses. Arch Neurol. 2001;58: Chimowitz MI. Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. Arch Neurol. 2001;58: Kam PC, Nethery CM. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia. 2003;58: Caplan LR. Caplan s Stroke: A Clinical Approach. 3rd ed. Boston, Mass: Butterworth-Heinemann; 2000: Barnes RW, Robertson JT. Surgical considerations in asymptomatic disease. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM. Stroke Pathophysiology, Diagnosis, and Management. 3rd ed. New York, NY: Churchill Livingstone; 1998: Borger MA, Fremes SE. Management of patients with concomitant coronary and carotid vascular disease. Semin Thorac Cardiovasc Surg. 2001;13: Spandorfer J. The management of anticoagulation before and after procedures. Med Clin North Am. 2001;85: Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Ann Intern Med. 2003;163: Blacker DJ, Wijdicks EF, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology. 2003;61: Mangano DT, Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 2002;347: Questions About the Preoperative Cerebrovascular Consultation 1. Which one of the following regarding stroke and general surgery is most accurate? a. Asymptomatic carotid stenosis is a risk factor for perioperative stroke b. Patients with symptomatic carotid stenosis are at high risk for stroke and should have this condition treated before undergoing other surgeries c. Carotid bruits are a marker for increased risk of perioperative stroke d. Middle cerebral artery stenosis has been shown to predict perioperative stroke e. Aortic arch atherosclerosis is a risk factor for perioperative stroke related to general surgery

7 Mayo Clin Proc, February 2004, Vol 79 Preoperative Cerebrovascular Consultation Which one of the following best describes the relationship between extracranial carotid stenosis and stroke related to CABG surgery? a. Carotid stenosis may cause a stroke during CABG surgery due to focal hypoperfusion, particularly if there is intraoperative hypotension b. Carotid stenosis may be a nidus for cerebral embolism during or after CABG surgery c. Carotid stenosis may be the cause of stroke or be a marker for aortic arch atherosclerosis that is the cause of stroke related to CABG surgery d. Carotid stenosis increases with age, which is the overwhelming factor predicting stroke related to CABG surgery e. The stroke mechanisms related to CABG surgery are too complex to be sure of the relationship 3. Which one of the following regarding CEA and CAS is true? a. CAS is an acceptable treatment for all patients with asymptomatic carotid stenosis b. Intracranial angioplasty and stenting should be performed for an asymptomatic midbasilar stenosis before CABG surgery c. CEA or CAS should be performed in patients with a 75% internal carotid artery stenosis and recent ipsilateral amaurosis fugax before elective abdominal surgery d. CEA or CAS should be performed in patients with an asymptomatic carotid bruit before CABG surgery for recent unstable angina e. Combined CEA and CABG surgery should be performed in patients with symptomatic carotid stenosis and a distant history of MI but with recent normal cardiac stress test results 4. Regarding the perioperative use of antiplatelet and anticoagulant medications, which one of the following is false? a. Clopidogrel should be continued throughout the perioperative period in a patient with an asymptomatic 80% carotid stenosis who is undergoing CABG surgery b. Aspirin should be continued throughout the perioperative period in a patient undergoing CABG surgery who has no history of stroke or TIA c. Early postoperative heparin is reasonable treatment for a patient with AF and a history of stroke who has an elective repair of an abdominal aortic aneurysm d. It would be reasonable to withhold warfarin for a few days and to not use heparin in a 55-year-old patient with nonvalvular AF who is undergoing elective clipping of an unruptured intracranial aneurysm e. Aspirin should be continued throughout the perioperative period in a 75-year-old patient with a history of stroke who is undergoing an open cholecystectomy 5. Which one of the following is true? a. A unilateral carotid bruit predicts a 3% chance of stroke during CABG surgery b. The procedure-related stroke risk for CEA in asymptomatic patients is greater than the stroke risk for CAS c. Carotid occlusion is associated with an increased risk for stroke related to CABG surgery d. The stroke risk related to general surgery is greater for patients with a distant history of stroke than for those with carotid stenosis e. The procedure-related stroke risk for CEA in asymptomatic patients with carotid stenosis is greater than the risk of general surgery in the setting of carotid stenosis Correct answers: 1. b, 2. c, 3. c, 4. a, 5. c

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO

More information

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL

APPENDIX A NORTH AMERICAN SYMPTOMATIC CAROTID ENDARTERECTOMY TRIAL APPENDIX A Primary Findings From Selected Recent National Institute of Neurological Disorders and Stroke-Sponsored Clinical Trials That Have shaped Modern Stroke Prevention Philip B. Gorelick 178 NORTH

More information

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary SOCIETY FOR VASCULAR SURGERY DOCUMENT Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary John J. Ricotta, MD, a Ali AbuRahma, MD, FACS, b

More information

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service M AY. 6. 2011 10:37 A M F D A - C D R H - O D E - P M O N O. 4147 P. 1 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control

More information

CEREBRO VASCULAR ACCIDENTS

CEREBRO VASCULAR ACCIDENTS CEREBRO VASCULAR S MICHAEL OPONG-KUSI, DO MBA MORTON CLINIC, TULSA, OK, USA 8/9/2012 1 Cerebrovascular Accident Third Leading cause of deaths (USA) 750,000 strokes in USA per year. 150,000 deaths in USA

More information

Open heart surgery or carotid endarterectomy. Which procedure should be done first?

Open heart surgery or carotid endarterectomy. Which procedure should be done first? Open heart surgery or carotid endarterectomy. Which procedure should be done first? Pedro Pinto Sousa 1, Gabriela Teixeira 2, João Gonçalves 2 ; Luís Vouga 1, Rui Almeida 2 ; Pedro Sá Pinto 2 1 Centro

More information

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h) Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase

More information

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME

More information

Guidelines for Ultrasound Surveillance

Guidelines for Ultrasound Surveillance Guidelines for Ultrasound Surveillance Carotid & Lower Extremity by Ian Hamilton, Jr, MD, MBA, RPVI, FACS Corporate Medical Director BlueCross BlueShield of Tennessee guidelines for ultrasound surveillance

More information

Lecture Outline: 1/5/14

Lecture Outline: 1/5/14 John P. Karis, MD Lecture Outline: Provide a clinical overview of stroke: Risk Prevention Diagnosis Intervention Illustrate how MRI is used in the diagnosis and management of stroke. Illustrate how competing

More information

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease

Disclosures. CREST Trial: Summary. Lecture Outline 4/16/2015. Cervical Atherosclerotic Disease Disclosures Your Patient Has Carotid Bulb Stenosis and a Tandem Intracranial Stenosis: How Do SAMMPRIS and Other Evidence Inform Your Treatment? UCSF Vascular Symposium 2015 Steven W. Hetts, MD Associate

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting Woong Chol Kang M.D. Gil Medical Center, Gachon University of Medicine and Science, Incheon, Korea Carotid Stenosis and Stroke ~25% of stroke is due to carotid disease, the reminder

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Endovascular Therapies for Extracranial Vertebral Artery Disease File Name: Origination: Last CAP Review: Next CAP Review: Last Review: endovascular_therapies_for_extracranial_vertebral_artery_disease

More information

Advances in the treatment of posterior cerebral circulation symptomatic disease

Advances in the treatment of posterior cerebral circulation symptomatic disease Advances in the treatment of posterior cerebral circulation symptomatic disease Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Faculty of Medicine, School of Health

More information

The assessment of patients with cerebrovascular disease

The assessment of patients with cerebrovascular disease Risk of Ischemic Stroke in Patients With Symptomatic Vertebrobasilar Stenosis Undergoing Surgical Procedures David J. Blacker, FRACP; Kelly D. Flemming, MD; Eelco F.M. Wijdicks, MD Background and Purpose

More information

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery

Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery 2011 65 4 239 245 Carotid Endarterectomy for Symptomatic Complete Occlusion of the Internal Carotid Artery a* a b a a a b 240 65 4 2011 241 9 1 60 10 2 62 17 3 67 2 4 64 7 5 69 5 6 71 1 7 55 13 8 73 1

More information

AN ASSESSMENT OF INTER-RATER RELIABILITY IN THE TREATMENT OF CAROTID ARTERY STENOSIS

AN ASSESSMENT OF INTER-RATER RELIABILITY IN THE TREATMENT OF CAROTID ARTERY STENOSIS Pak Heart J ORIGINAL ARTICLE AN ASSESSMENT OF INTER-RATER RELIABILITY IN THE TREATMENT OF CAROTID ARTERY STENOSIS 1 2 3 4 5 Abhishek Nemani, Arshad Ali, Arshad Rehan, Ali Aboufaris, Jabar Ali 1-4 Guthrie

More information

Management of combined coronary & carotid disease

Management of combined coronary & carotid disease Management of combined coronary & carotid disease Combined Carotid and coronary artery diseases Frequent combination Fear of imminent death psychologically traumatic for the patients and their families

More information

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO

Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Carotid Artery Disease and What s Pertinent JOSEPH A PAULISIN DO Goal of treatment of carotid disease Identify those at risk of developing symptoms Prevent patients at risk from developing symptoms Prevent

More information

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008

New Trials in Progress: ACT 1. Jon Matsumura, MD Cannes, France June 28, 2008 New Trials in Progress: ACT 1 Jon Matsumura, MD Cannes, France June 28, 2008 Faculty Disclosure I disclose the following financial relationships: Consultant, CAS training director, and/or research grants

More information

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30 Active Cardiac Conditions for Which the Patient Should Undergo Evaluation

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million life insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014

Carotid Artery Revascularization: Current Strategies. Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Carotid Artery Revascularization: Current Strategies Shonda Banegas, D.O. Vascular Surgery Carondelet Heart and Vascular Institute September 6, 2014 Disclosures None 1 Stroke in 2014 Stroke kills almost

More information

Original Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit

Original Contributions. Prospective Comparison of a Cohort With Asymptomatic Carotid Bruit and a Population-Based Cohort Without Carotid Bruit 98 Original Contributions Prospective Comparison of a Cohort With Carotid Bruit and a Population-Based Cohort Without Carotid Bruit David O. Wiebers, MD, Jack P. Whisnant, MD, Burton A. Sandok, MD, and

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine

Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Vivek R. Deshmukh, MD Director, Cerebrovascular and Endovascular Neurosurgery Chairman, Department of Neurosurgery Providence Brain and Spine Institute The Oregon Clinic Disclosure I declare that neither

More information

How to manage the left subclavian and left vertebral artery during TEVAR

How to manage the left subclavian and left vertebral artery during TEVAR How to manage the left subclavian and left vertebral artery during TEVAR Jürg Schmidli Chief of Vascular Surgery Inselspital Hamburg 2017 Dept Cardiovascular Surgery, Bern, Switzerland Disclosure No Disclosures

More information

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance

MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS. 73 year old NS right-handed male applicant for $1 Million Life Insurance MORTALITY AND MORBIDITY RISK FROM CAROTID ARTERY ATHEROSCLEROSIS October 17, 2012 AAIM Triennial Conference, San Diego Robert Lund, MD What Is The Risk? 73 year old NS right-handed male applicant for $1

More information

Vertebrobasilar Insufficiency

Vertebrobasilar Insufficiency Equilibrium Res Vol. (3) Vertebrobasilar Insufficiency Toshiaki Yamanaka Department of Otolaryngology-Head and Neck Surgery, Nara Medical University School of Medicine Vertebrobasilar insufficiency (VBI)

More information

Joshua A. Beckman, MD. Brigham and Women s Hospital

Joshua A. Beckman, MD. Brigham and Women s Hospital Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham

More information

Contemporary Management of Carotid Disease What We Know So Far

Contemporary Management of Carotid Disease What We Know So Far Contemporary Management of Carotid Disease What We Know So Far Ammar Safar, MD, FSCAI, FACC, FACP, RPVI Interventional Cardiology & Endovascular Medicine Disclosers NONE Epidemiology 80 % of stroke are

More information

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery

Treatment Considerations for Carotid Artery Stenosis. Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery Treatment Considerations for Carotid Artery Stenosis Danielle Zielinski, RN, MSN, ACNP Rush University Neurosurgery 4.29.2016 There is no actual or potential conflict of interest in regards to this presentation

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Amy B. Reed, MD, a Peter Gaccione, MA, b Michael Belkin, MD, b Magruder C. Donaldson, MD, b John A. Mannick, MD,

More information

Original Contributions. Brain Damage After Open Heart Surgery in Patients With Acute Cardioembolic Stroke

Original Contributions. Brain Damage After Open Heart Surgery in Patients With Acute Cardioembolic Stroke 305 Original Contributions Brain Damage After Open Heart Surgery in Patients With Acute Cardioembolic Stroke Michiyuki Maruyama, MD, Yoshihiro Kuriyama, MD, Tohru Sawada, MD, Takenori Yamaguchi, MD, Tsuyoshi

More information

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for

Post-op Carotid Complications A Nursing Perspective of What to Watch Out for Post-op Carotid Complications A Nursing Perspective of What to Watch Out for By Kariss Peterson, ARNP Swedish Medical Center Inpatient Neurology Team 1 Post-op Carotid Management Objectives Review the

More information

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure

Slide 1. Slide 2 Conflict of Interest Disclosure. Slide 3 Stroke Facts. The Treatment of Intracranial Stenosis. Disclosure Slide 1 The Treatment of Intracranial Stenosis Helmi Lutsep, MD Vice Chair and Dixon Term Professor, Department of Neurology, Oregon Health & Science University Chief of Neurology, VA Portland Health Care

More information

GUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY

GUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY GUIDELINE FOR RECOVERY ROOM MANAGEMENT OF PATIENTS AFTER CAROTID ENDARTERECTOMY Full Title of Guideline: Author (include email and role): Guideline for Recovery Room Management of Patients after Carotid

More information

Carotid Artery Stenting

Carotid Artery Stenting Carotid Artery Stenting JESSICA MITCHELL, ACNP CENTRAL ILLINOIS RADIOLOGICAL ASSOCIATES External Carotid Artery (ECA) can easily be identified from Internal Carotid Artery (ICA) by noticing the branches.

More information

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion

Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Recanalization of Chronic Carotid Artery Occlusion Objective Improvement Of Cerebral Perfusion Paul Hsien-Li Kao, MD Assistant Professor National Taiwan University Medical School and Hospital ICA stenting

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACAS (Asymptomatic Carotid Atherosclerosis Study), 65 66 ACST (Asymptomatic Carotid Surgery Trial), 6 7, 65, 75 Age factors, in carotid

More information

Prevention and Management of Cardiac Adverse Event

Prevention and Management of Cardiac Adverse Event Prevention and Management of Cardiac Adverse Event Carlo Cernetti Department of Interventional Cardiology Mirano (Italy) Cannes MEEC 14 June 2007 Are these risks factors of Haemodynamic Instability

More information

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events. ACETYL SALICYLIC ACID TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

More information

Algorithmic selection of emboli protection device during the procedure of carotid artery stunting

Algorithmic selection of emboli protection device during the procedure of carotid artery stunting Algorithmic selection of emboli protection device during the procedure of carotid artery stunting Yasuhiro Kawabata, Tetsuya Tsukahara, Shunichi Fukuda, Tomokazu Aoki, Satoru Kawarazaki Department of Neurosurgery,

More information

COMPARISON OF 2014 ACCAHA VS. ESC GUIDELINES EDITORIAL

COMPARISON OF 2014 ACCAHA VS. ESC GUIDELINES EDITORIAL COMPARISON OF 2014 ACCAHA VS. ESC GUIDELINES EDITORIAL Guidelines in review: Comparison of the 2014 ACC/AHA guidelines on perioperative cardiovascular evaluation and management of patients undergoing noncardiac

More information

TCT mdbuyline.com Clinical Trial Results Summary

TCT mdbuyline.com Clinical Trial Results Summary TCT 2012 Clinical Trial Results Summary FAME2 Trial: FFR (fractional flow reserve) guided PCI in all target lesions Patients with significant ischemia, randomized 1:1 Control arm: not hemodynamically significant

More information

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE Elizabeth L. Detschelt, M.D. Allegheny Health Network Vascular and Endovascular Symposium April 2, 2016 DISCLOSURES I have no

More information

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS

TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS TCAR: TransCarotid Artery Revascularization Angela A. Kokkosis, MD, RPVI, FACS Assistant Professor of Surgery Director of Carotid Interventions Division of Vascular & Endovascular Surgery Stony Brook University

More information

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai

CardioLucca2014. Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee. Fabrizio Tomai CardioLucca2014 Fare luce sulla scelta ottimale del trattamento nella rivascolarizzazione delle stenosi carotidee Fabrizio Tomai European Hospital e Aurelia Hospital Roma Treatment of Carotid Artery Disease

More information

Introduction. Risk factors of PVD 5/8/2017

Introduction. Risk factors of PVD 5/8/2017 PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental

More information

Cerebral hyperperfusion syndrome after carotid angioplasty

Cerebral hyperperfusion syndrome after carotid angioplasty case report Cerebral hyperperfusion syndrome after carotid angioplasty Zoran Miloševič 1, Bojana Žvan 2, Marjan Zaletel 2, Miloš Šurlan 1 1 Institute of Radiology, 2 University Neurology Clinic, University

More information

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease

Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Clinical Decision Making: Hyperacute Management of Symptomatic Carotid Artery Disease Tarvinder Singh, MS, MD Neurohospitalist Swedish Neuroscience Institute 1 Objectives Definition Why the urgency? Evidence/Guidelines

More information

Chapter 4 Section 9.1

Chapter 4 Section 9.1 Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,

More information

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre

Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Dr Julia Hopyan Stroke Neurologist Sunnybrook Health Sciences Centre Objectives To learn what s new in stroke care 2010-11 1) Acute stroke management Carotid artery stenting versus surgery for symptomatic

More information

Carotid Revascularization

Carotid Revascularization Options for Carotid Disease Carotid Revascularization Wayne Causey, MD 2 nd Year Vascular Surgery Fellow Best medical therapy, Carotid Endarterectomy, and Carotid Stenting Who benefits from best medical

More information

Asif Serajian DO FACC FSCAI

Asif Serajian DO FACC FSCAI Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac

More information

Subclavian artery Stenting

Subclavian artery Stenting Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence

More information

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009

Cerebrovascular Disease. RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease RTC Conference Resident Presenter: Dr. Christina Bailey Faculty: Dr. Jeff Dattilo October 2, 2009 Cerebrovascular Disease Stroke is the 3 rd leading cause of death and the leading

More information

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with

More information

Long-Term Care Updates

Long-Term Care Updates Long-Term Care Updates October/November 2015 By Daniel Kerner, PharmD A stroke occurs when blood flow to the brain is stopped or slowed, resulting in death or damage to brain cells. There are three main

More information

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE?

UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? UPMC HAMOT CAROTID ARTERY DISEASE WHERE DO WE GO FROM HERE? Richard W. Petrella M.D. FACP,FACC,FASCI DEPARTMENT CHAIRMAN CVM&S UPMC HAMOT MEDICAL CENTER 1 LEARNING OBJECTIVES REVIEW THE RISK FACTORS FOR

More information

Chapter 4 Section 9.1

Chapter 4 Section 9.1 Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33200-37186, 37195-37785, 92950-93272, 93303-93581,

More information

The Struggle to Manage Stroke, Aneurysm and PAD

The Struggle to Manage Stroke, Aneurysm and PAD The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology

More information

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic

Disclosures. State of the Art Management of Carotid Stenosis. NIH funding for clinical trials Consultant for Scientia Vascular and Medtronic State of the Art Management of Carotid Stenosis Mark R. Harrigan, MD UAB Stroke Center Professor of Neurosurgery, Neurology, and Radiology University of Alabama, Birmingham Disclosures NIH funding for

More information

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Introduction This Clinician Guide is based on the 2017 KP National Coronary Artery Disease

More information

Management of Carotid Disease CHRISTOPHER LAU PGY-3 BROOKLYN VA

Management of Carotid Disease CHRISTOPHER LAU PGY-3 BROOKLYN VA Management of Carotid Disease CHRISTOPHER LAU PGY-3 BROOKLYN VA SUNY DOWNSTATE MEDICAL CENTER Case 61 year old male referred to Vascular Surgery for left internal carotid stenosis Presented with transient

More information

The learning curve associated with intracranial angioplasty and stenting: analysis from a single center

The learning curve associated with intracranial angioplasty and stenting: analysis from a single center Original Article Page 1 of 7 The learning curve associated with intracranial angioplasty and stenting: analysis from a single center Peiquan Zhou, Guang Zhang, Zhiyong Ji, Shancai Xu, Huaizhang Shi Department

More information

Preoperative Management of Patients Receiving Antithrombotics

Preoperative Management of Patients Receiving Antithrombotics Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate?

Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know. Case 1 4/5/11. What treatment should you initiate? Advances in Prevention and Treatment of Stroke: What Every Primary Care Physician Needs to Know S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University

More information

Carotid Disease and CABG: What is the best Treatment

Carotid Disease and CABG: What is the best Treatment Carotid Disease and CABG: What is the best Treatment Dual Antiplatelets Luis A Guzman, MD, FACC, FSCAI Professor of Medicine Director, Cardiovascular Cath Lab Virginia Commonwealth University Stroke during

More information

Michael Horowitz, MD Pittsburgh, PA

Michael Horowitz, MD Pittsburgh, PA Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion

More information

Extracranial Carotid Artery Stenting With or Without Distal Protection Device

Extracranial Carotid Artery Stenting With or Without Distal Protection Device Extracranial Carotid Artery Stenting With or Without Distal Protection Device Eak-Kyun Shin MD. Professor of Medicine Division of Cardiology, Heart Center, Gil Medical Center Gacheon Medical School Incheon,

More information

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY WHICH PATIENT IS AT HIGHEST RISK? 1. 70 yo asymptomatic patient with history of heart failure

More information

CAROTID ARTERY ANGIOPLASTY

CAROTID ARTERY ANGIOPLASTY CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline

More information

Debata II: Carotidal stenting v.s. carotidal endatherectomy- surgical side

Debata II: Carotidal stenting v.s. carotidal endatherectomy- surgical side Debata II: Carotidal stenting v.s. carotidal endatherectomy- surgical side Academician Mitrev Z, Special hospital for surgery Filip Vtori Skopje - Macedonija Oktomvri, 2008 History Hippocrates, 400 B.C.

More information

Asymptomatic Carotid Stenosis To Do or Not To Do

Asymptomatic Carotid Stenosis To Do or Not To Do Asymptomatic Carotid Stenosis To Do or Not To Do October 22, 2016 Neurosciences: Updates and Controversies Andrew C. MacDougall, MD Advocate Medical Group Advocate Lutheran General Hospital Principle

More information

Cryptogenic Strokes: Evaluation and Management

Cryptogenic Strokes: Evaluation and Management Cryptogenic Strokes: Evaluation and Management 77 yo man with hypertension and hyperlipidemia developed onset of left hemiparesis and right gaze preference, last seen normal at 10:00 AM Brought to ZSFG

More information

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity? Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication

More information

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD] 2015 PHYSICIAN SIGN-OFF (1) STUDY NO (PHY-1) CASE, PER PHYSICIAN REVIEW 1=yes 2=no [strictly meets case definition] (PHY-1a) CASE, IN PHYSICIAN S OPINION 1=yes 2=no (PHY-2) (PHY-3) [based on all available

More information

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals. OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral

More information

2015 Update in Diagnosis and Management of Stroke

2015 Update in Diagnosis and Management of Stroke 2015 Update in Diagnosis and Management of Stroke S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Senior Executive Vice Chair, Department

More information

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES ALBERTO MAUD, MD ASSOCIATE PROFESSOR TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER EL PASO PAUL L. FOSTER SCHOOL OF MEDICINE 18TH ANNUAL RIO GRANDE TRAUMA 2017

More information

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Carotid Artery Disease How the 2014-2015 Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient Christopher J. White, MD, MSCAI, FACC, FAHA, FESC Professor and Chair of Medicine Ochsner

More information

TIA: Updates and Management 2008

TIA: Updates and Management 2008 TIA: Updates and Management 2008 S. Andrew Josephson, MD Department of Neurology, Neurovascular Division University of California San Francisco Commonly Held TIA Misconceptions TIA is easy to diagnose

More information

Surgical Treatment of Carotid Disease

Surgical Treatment of Carotid Disease Department of Cardiothoracic & Vascular Surgery McGovern Medical School / The University of Texas Health Science Center at Houston Surgical Treatment of Carotid Disease The Old, the New, and the Future

More information

Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale?

Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale? ORIGINAL ARTICLE Is Stroke a Paradoxical Embolism in Patients with Patent Foramen Ovale? Masahiro YASAKA, Ryoichi OTSUBO, Hiroshi OE and Kazuo MINEMATSU Abstract Objective Purpose was to assess the stroke

More information

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2

DESCRIPTION: Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2 Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Patient Safety

More information

PCI for Renal Artery stenosis

PCI for Renal Artery stenosis PCI for Renal Artery stenosis Why should we treat Renal Artery Stenosis? Natural History of RAS RAS is progressive disease Study Follow-up (months) Pts Progression N (%) Total occlusion Wollenweber Meaney

More information

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

More information

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction Doron Aronson MD, Gregory Telman MD, Fadel BahouthMD, Jonathan Lessick MD, DSc and Rema Bishara MD Department of Cardiology

More information

Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology

Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology Guiding Secondary Stroke Prevention through Evaluation of Ischemic Stroke Etiology Ann M. Leonhardt Caprio, MS, RN, ANP-BC Program Coordinator Comprehensive Stroke Center, Strong Memorial Hospital Clinical

More information

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management

Canadian Best Practice Recommendations for Stroke Care. (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Section # 3 Hyperacute Stroke Management Reorganization of Recommendations 2008 2006 RECOMMENDATIONS: 2008 RECOMMENDATIONS:

More information

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):

More information

Carotid Artery Stent: Is it ready for prime time?

Carotid Artery Stent: Is it ready for prime time? 2010 CATH LAB SYMPOSIUM Carotid Artery Stent: Is it ready for prime time? Luis F. Tami, MD, FACC, FSCAI Interventional Cardiology and Vascular Medicine Memorial Regional Hospital August 2010 CAE and CAS

More information

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis

Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Management of intracranial atherosclerotic stenosis (ICAS)/intracranial atherosclerosis Tim Mikesell, D.O. Oct 22, 2016 Stroke facts Despite progress in decreasing stroke incidence and mortality, stroke

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #344: Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) National Quality Strategy Domain: Effective Clinical

More information

Chapter 4 Section 9.1

Chapter 4 Section 9.1 Surgery Chapter 4 Section 9.1 Issue Date: August 26, 1985 Authority: 32 CFR 199.4(c)(2) and (c)(3) 1.0 CPT 1 PROCEDURE CODES 33010-33130, 33140, 33141, 33361-33369, 33200-37186, 37195-37785, 92950-93272,

More information

Carotid Stenting and Surgery in 2016 in Russia

Carotid Stenting and Surgery in 2016 in Russia Carotid Stenting and Surgery in 2016 in Russia Novosibirsk research institute of circulation pathology named by Meshalkin, Novosibirsk, Russia Starodubtsev V., Karpenko A., Ignatenko P. Annually in Russia

More information